Oticon Medical today announced that the US Food and Drug Administration (FDA) has granted premarket approval (PMA) to the company’s Neuro System to treat individuals 18 years or older, with bilateral ...
The use of intelligent systems is growing rapidly. One of these is the Neuro-Fuzzy System. It is the result in a hybrid intelligent system that synergizes two techniques. Provide two possible ...
SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 1, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise ...
SOMERSET, N.J.--(BUSINESS WIRE)--Oticon Medical today announced that the US Food and Drug Administration (FDA) has granted premarket approval (PMA) to the company’s Neuro System to treat individuals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results